Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 08:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular...
November 03, 2025 06:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA salesMore than 2,000 unique patient prescriptions and...
October 27, 2025 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease,...
October 07, 2025 06:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease,...
September 29, 2025 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting

MORRISVILLE, N.C., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary...
September 11, 2025 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium

MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease,...
August 27, 2025 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

MORRISVILLE, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that members of the company’s executive leadership team will be providing an update on the...
August 12, 2025 06:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUTREPIA™ surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILDPositive interim data from ASCENT trial reinforces YUTREPIA’s...
August 05, 2025 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025

MORRISVILLE, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease,...
June 23, 2025 16:34 ET | Source: Liquidia Technologies, Inc.

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease,...